Our Pricing

Understanding Wegovy Pen Doses and Dosing Schedules

Published on: June 03, 2026

If you're researching wegovy pen doses UK online prescription options, understanding the dosing structure is essential before starting treatment. Each Wegovy pen contains four individual doses administered once weekly, with a carefully structured escalation plan designed to minimise side effects whilst optimising weight loss outcomes [1]. At Cured Pharmacy, our UK-registered prescribers provide fast online assessments, transparent pricing from £79.00, and discreet delivery of genuine MHRA-licensed Wegovy pens.

How Many Doses Are in Each Wegovy Pen?

Every Wegovy pen is a pre-filled, single-dose injector pen containing exactly one dose of semaglutide [1]. Unlike multi-dose insulin pens, each Wegovy pen is designed for one-time use only and should be disposed of safely after administration. Patients receive four individual pens per monthly pack, corresponding to the four weekly injections required during each dose-strength phase.

The confusion often arises because Wegovy treatment involves multiple dose strengths over time. You'll progress through five distinct dose levels — 0.25mg, 0.5mg, 1mg, 1.7mg, and the maintenance dose of 2.4mg — but each pen at every strength level contains just one dose [2]. This single-dose design ensures accurate dosing, reduces medication errors, and maintains sterility throughout your treatment journey.

Wegovy Dose Escalation Schedule Explained

Wegovy follows a structured 16-week dose escalation protocol mandated by the MHRA to improve gastrointestinal tolerability [2]. You begin with 0.25mg weekly for the first month (four pens), then increase to 0.5mg weekly for the second month (four pens). Month three introduces 1mg weekly doses, followed by 1.7mg in month four. From month five onwards, you maintain the target dose of 2.4mg weekly [1][2].

This gradual titration approach significantly reduces the incidence of nausea, vomiting, and diarrhoea compared to starting at higher doses. In the STEP clinical trial programme, patients following this escalation schedule reported better treatment adherence and fewer discontinuations due to gastrointestinal side effects [3]. Your UK prescriber may adjust this timeline if you experience persistent side effects, occasionally extending a dose phase by an additional month before progressing.

What Happens If You Miss a Dose?

If you miss your scheduled Wegovy injection and fewer than five days have passed, administer the missed dose as soon as you remember, then resume your normal weekly schedule [2]. However, if more than five days have elapsed since your missed dose, skip it entirely and take your next dose on the regularly scheduled day. Never double up doses to compensate for a missed injection, as this increases the risk of severe gastrointestinal adverse effects and does not improve weight loss outcomes.

Clinical Evidence: Wegovy Pen Doses and Weight Loss Outcomes

The STEP 1 trial demonstrated that patients following the complete Wegovy dosing schedule achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [3]. Importantly, outcomes were significantly better among participants who completed the full dose escalation protocol and maintained the 2.4mg weekly maintenance dose throughout the study period.

Subgroup analysis revealed that patients who remained on lower doses (1mg or 1.7mg weekly) due to tolerability concerns still achieved meaningful weight loss, averaging 10-12% body weight reduction [3][4]. This evidence supports the flexibility UK prescribers have in tailoring your maintenance dose based on individual response and side effect profile, rather than rigidly adhering to the 2.4mg target if it proves unsuitable for your circumstances.

Comparing Wegovy Doses to Other GLP-1 Treatments

Wegovy's semaglutide 2.4mg weekly dose represents the highest approved GLP-1 receptor agonist dose for weight management in the UK. Saxenda, containing liraglutide, requires daily 3mg injections, whilst Mounjaro uses tirzepatide in a dual GIP/GLP-1 mechanism with doses ranging up to 15mg weekly [4]. The once-weekly administration schedule of Wegovy pen doses offers superior convenience compared to daily injection regimens, contributing to better long-term adherence rates observed in real-world prescription data.

How to Use Your Wegovy Pen Correctly

Wegovy pens are designed for subcutaneous injection into the abdomen, thigh, or upper arm [2]. Before each injection, inspect the pen window to ensure the solution is clear and colourless — do not use if cloudy, discoloured, or containing particles. Remove the pen cap, place the pen firmly against your chosen injection site at a 90-degree angle, and press the dose button until you hear a click. Hold the pen in place for six seconds to ensure full dose delivery before withdrawing.

Rotate injection sites weekly to prevent lipohypertrophy (fatty lumps under the skin) which can impair semaglutide absorption and reduce treatment efficacy [2]. Many patients find it helpful to inject on the same day each week — choosing a consistent day like Sunday evening improves adherence and simplifies scheduling around social commitments. Store unused Wegovy pens in the refrigerator between 2°C and 8°C, but never freeze them. Once you've started using a pen, you may store it at room temperature (below 30°C) for up to 28 days if needed for travel convenience.

Getting Your Wegovy Pen Doses with Fast UK Online Prescription

At Cured Pharmacy, our streamlined online consultation takes under three minutes to complete and is reviewed by UK-registered prescribers, including our superintendent pharmacist Tarun Kumar (GPhC 2233073). The assessment covers your medical history, current medications, weight loss goals, and any contraindications to semaglutide therapy. Subject to prescriber approval, your Wegovy pens are dispensed from our GPhC-registered pharmacy (9012511) and delivered in discreet packaging directly to your UK address.

Transparent pricing starts from £79.00 per month, with the exact cost displayed before you complete your consultation — no hidden fees or surprise charges at checkout. We supply only genuine MHRA-licensed Wegovy manufactured by Novo Nordisk, never grey-market imports or compounded alternatives. Your prescription includes full patient information leaflets, injection technique guides, and access to our pharmacy team on (+44) 116 4646009 for any dosing questions throughout your treatment journey.

Who Can Prescribe Wegovy in the UK?

Wegovy is a prescription-only medication in the UK and can only be prescribed by registered medical professionals following clinical assessment [1]. At Cured Pharmacy, all prescribing decisions are made by UK-registered doctors and prescribing pharmacists who are qualified to assess your suitability for semaglutide therapy. NICE guidelines recommend Wegovy for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities such as type 2 diabetes, hypertension, or obstructive sleep apnoea [5].

Managing Side Effects During Wegovy Dose Escalation

Gastrointestinal side effects are most common during the initial dose escalation phases, with nausea reported by approximately 44% of patients in clinical trials, typically peaking during the first 8-12 weeks [3]. These effects usually diminish as your body adjusts to each new dose strength. To minimise discomfort, eat smaller, more frequent meals, avoid high-fat foods, and stay well-hydrated throughout the day.

If side effects become severe or persistent, contact your prescriber before your next scheduled dose increase. They may recommend extending your current dose phase by an additional month or, in some cases, reducing to the previous dose strength temporarily [2]. Approximately 7% of trial participants discontinued Wegovy due to adverse effects, most commonly nausea and vomiting, but the majority of patients successfully completed the full escalation schedule with supportive management strategies [3][4].

Scientific References

1. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy (semaglutide) injection: Prescribing Information. UK Summary of Product Characteristics. MHRA Approved Documentation. [accessed 13 August 2026]
3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
5. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. NICE Technology Appraisal Guidance [TA875]. Retrieved from https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on multiple factors including diet, exercise, and adherence to prescribed treatment regimens.